人禽流感病毒H5N1多价重组痘苗病毒（天坛株）疫苗在小鼠中的免疫原性研究  

Characterization of immune response in mice induced by recombinant vaccinia virus（Tiantan） based multivalent H5N1 avian influenza vaccines

作　　者：王文[1] 邓瑶[2] 谭文杰[2] 陈红[1] 王敏[1] 殷霄[1] 管洁[1] 周剑芳[1,2] 舒跃龙[1,2] 阮力[1] 

机构地区：[1]中国疾病预防控制中心病毒病预防控制所,北京100052 [2]中国疾病预防控制中心病毒基因工程重点实验室,北京100052

出　　处：《中华微生物学和免疫学杂志》2010年第6期546-550,共5页Chinese Journal of Microbiology and Immunology

基　　金：“十一五”国家科技支撑计划项目（2006BAD06A15）;国家重点研究发展计划（973）项目（2005CB523000）;国家自然科学基金重大项目（30599433）

摘　　要：目的 研发高效广谱的人高致病性禽流感病毒H5N1实验疫苗.方法 首先构建了含H5N1（安徽株）结构基因[血凝素（HA）、神经氨酸酶（NA）、基质蛋白M1与M2]的两个双顺反子（HAop/M2,NAop/M1）重组痘苗病毒（rTTV天坛株）疫苗,采用不同剂量（104 PFU或107PFU）或组合（疫苗单独或联合）方式于0、4周二次免疫BALB/c小鼠,初步比较分析抗原特异的体液（HA血凝抑制抗体、NA特异性抗体、中和抗体）与细胞免疫应答（IFN-γ ELISPOT）特点.结果 重组痘苗病毒疫苗可有效表达H5N1靶抗原;高剂量组的重组痘苗病毒疫苗可快速激发较强的针对各个抗原的抗体与针对血凝素与神经氨酸酶蛋白的细胞免疫应答,含血凝素蛋白的重组痘苗病毒疫苗亦可诱导明显的中和抗体;但各组重组痘苗病毒疫苗所激发的针对基质蛋白（M1,M2）的细胞免疫应答均较弱;两个双顺反子（HAop/M2,NAop/M1）重组痘苗病毒疫苗联合应用所激发的针对基质蛋白2（M2）的体液免疫应答明显强于单双顺反子（HAop/M2）疫苗单独应用.结论 本研究中制备的各组重组痘苗病毒疫苗可诱导多个抗原特异的体液与细胞免疫应答,该研究为新型H5N1疫苗的研发及免疫方案的优化奠定了基础.Objective To develop an effective and broad immune protective H5N1 vaccine.Methods We first developed two recombinant vaccinia （ Tiantan strain） virus （ rTTV ） based H5N1 vaccines, which consisted of bicistron expressing the hemagglutinin（HA） and matrix protein 2（M2）, or bicistron expressing the neuraminidase（NA） and matrix protein 1 （M1）. The expression of H5N1 protein in rTTVs was confirmed. We immunized the BALB/c mice twice with two kind of dose （ 104 PFU, 107 PFU）using different combination. Subsequently, we assessed the humoral and cellular immune response in vaccinated mice. Results Our data showed that rTTV-based H5N1 vaccine induced rapidly robust HA- and NAspecific antibody level and IFN-γ secreting form cell（SFC） with either single dose of 107 PFU or twice dose of 104 PFU or 107 PFU. We also detected significant neutralizing antibody and matrix-specific immune response. In addition, we found that immunization with two kind of rTTV-based H5N1 vaccines induced much high level of M2-specific antibody than that with single of rTTV-based H5N1 vaccine. Conclusion rTTVbased H5N1 vaccines in this study elicited board array of immunity and our study offers a promising alternative H5N1 vaccine candidates with favorable potential to prevent various H5N1 pandemic.

关 键 词：人高致病性禽流感病毒 H5N1 重组痘苗病毒(天坛株) 活病毒载体疫苗 

分 类 号：R3[医药卫生—基础医学]